Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

CHRONIC ENCEPHALOMYELITIS WITH SPECIFIC INCREASE IN INTRATHECAL MUMPS ANTIBODIES

Identifieur interne : 001686 ( Main/Exploration ); précédent : 001685; suivant : 001687

CHRONIC ENCEPHALOMYELITIS WITH SPECIFIC INCREASE IN INTRATHECAL MUMPS ANTIBODIES

Auteurs : Antti Vaheri [Finlande] ; Ilkka Julkunen [Finlande] ; Marja-Leena Koskiniemi [Finlande]

Source :

RBID : ISTEX:79E24744BB9DB8750D760A50C64896A62FF66760

English descriptors

Abstract

Abstract: Symptoms of severe encephalomyelitis developed in a 31-year-old man in 1967. He had a high serum antibody titre to mumps virus associated with a polymorphic cell reaction and an increased protein concentration in cerebrospinal fluid (CSF). He recovered considerably within a year and was able to resume work. In 1975 his condition deteriorated again; it improved during the following few years, but a further deterioration then occurred. In March, 1981, the complement-fixing antibody titre to mumps virus was 1/32 in the serum and 1/4 in the CSF. In November, 1981, the CSF IgG index was increased and the altered serum/CSF antibody ratio persisted. The specificity of the altered antibody ratio was confirmed by the single radial haemolysis test and an immunoassay specific for mumps virus. Antibodies against the mumps virus envelope glycoprotein, M-protein, and nucleoprotein could be demonstrated by immunoprecipitation and the antibody patterns in serum and CSF were similar. Antibodies against other microorganisms were not detected in the patient's CSF, and mumps antibodies were not found in the CSF specimens of 57 control patients. This case may be an example of a new disease—chronic mumps virus infection in the central nervous system.

Url:
DOI: 10.1016/S0140-6736(82)90713-9


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>CHRONIC ENCEPHALOMYELITIS WITH SPECIFIC INCREASE IN INTRATHECAL MUMPS ANTIBODIES</title>
<author>
<name sortKey="Vaheri, Antti" sort="Vaheri, Antti" uniqKey="Vaheri A" first="Antti" last="Vaheri">Antti Vaheri</name>
</author>
<author>
<name sortKey="Julkunen, Ilkka" sort="Julkunen, Ilkka" uniqKey="Julkunen I" first="Ilkka" last="Julkunen">Ilkka Julkunen</name>
</author>
<author>
<name sortKey="Koskiniemi, Marja Leena" sort="Koskiniemi, Marja Leena" uniqKey="Koskiniemi M" first="Marja-Leena" last="Koskiniemi">Marja-Leena Koskiniemi</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:79E24744BB9DB8750D760A50C64896A62FF66760</idno>
<date when="1982" year="1982">1982</date>
<idno type="doi">10.1016/S0140-6736(82)90713-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-SBV3F0H3-1/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000536</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000536</idno>
<idno type="wicri:Area/Istex/Curation">000516</idno>
<idno type="wicri:Area/Istex/Checkpoint">000802</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000802</idno>
<idno type="wicri:doubleKey">0140-6736:1982:Vaheri A:chronic:encephalomyelitis:with</idno>
<idno type="wicri:Area/Main/Merge">001715</idno>
<idno type="wicri:Area/Main/Curation">001686</idno>
<idno type="wicri:Area/Main/Exploration">001686</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">CHRONIC ENCEPHALOMYELITIS WITH SPECIFIC INCREASE IN INTRATHECAL MUMPS ANTIBODIES</title>
<author>
<name sortKey="Vaheri, Antti" sort="Vaheri, Antti" uniqKey="Vaheri A" first="Antti" last="Vaheri">Antti Vaheri</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Departments of Virology and Neurology, University of Helsinki, SF-00290 Helsinki 29</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Julkunen, Ilkka" sort="Julkunen, Ilkka" uniqKey="Julkunen I" first="Ilkka" last="Julkunen">Ilkka Julkunen</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Departments of Virology and Neurology, University of Helsinki, SF-00290 Helsinki 29</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Koskiniemi, Marja Leena" sort="Koskiniemi, Marja Leena" uniqKey="Koskiniemi M" first="Marja-Leena" last="Koskiniemi">Marja-Leena Koskiniemi</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Departments of Virology and Neurology, University of Helsinki, SF-00290 Helsinki 29</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">The Lancet</title>
<title level="j" type="abbrev">LANCET</title>
<idno type="ISSN">0140-6736</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1982">1982</date>
<biblScope unit="volume">320</biblScope>
<biblScope unit="issue">8300</biblScope>
<biblScope unit="page" from="685">685</biblScope>
<biblScope unit="page" to="688">688</biblScope>
</imprint>
<idno type="ISSN">0140-6736</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0140-6736</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Antibody</term>
<term>Antibody patterns</term>
<term>Antibody production</term>
<term>Antibody ratio</term>
<term>Antibody response</term>
<term>Aqueductal stenosis</term>
<term>Bactericidal activity</term>
<term>Cerebrospinal fluid</term>
<term>Chlamydia group antigen</term>
<term>Chronic encephalomyelitis</term>
<term>Chronic infections</term>
<term>Clin microbiol</term>
<term>Control patients</term>
<term>Enzyme immunoassay</term>
<term>Further deterioration</term>
<term>Fusion protein</term>
<term>Measles</term>
<term>Measles virus</term>
<term>Multiple sclerosis</term>
<term>Mumps</term>
<term>Mumps antibodies</term>
<term>Mumps meningitis</term>
<term>Mumps virus</term>
<term>Mumps virus infection</term>
<term>Mycoplasma pneumoniae</term>
<term>Neuropsychological deficiences</term>
<term>Normal range</term>
<term>Oligoclonal</term>
<term>Outpatient clinic</term>
<term>Panencephalitis</term>
<term>Positive babinski sign</term>
<term>Present case</term>
<term>Protein concentration</term>
<term>Pseudomonas</term>
<term>Respiratory syncytial</term>
<term>Rubella</term>
<term>Sclerosing</term>
<term>Serum mumps</term>
<term>Sick children</term>
<term>Specific increase</term>
<term>Structural proteins</term>
<term>Subacute</term>
<term>Subacute sclerosing panencephalitis</term>
<term>Toxoplasma gondii</term>
<term>Virus</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Symptoms of severe encephalomyelitis developed in a 31-year-old man in 1967. He had a high serum antibody titre to mumps virus associated with a polymorphic cell reaction and an increased protein concentration in cerebrospinal fluid (CSF). He recovered considerably within a year and was able to resume work. In 1975 his condition deteriorated again; it improved during the following few years, but a further deterioration then occurred. In March, 1981, the complement-fixing antibody titre to mumps virus was 1/32 in the serum and 1/4 in the CSF. In November, 1981, the CSF IgG index was increased and the altered serum/CSF antibody ratio persisted. The specificity of the altered antibody ratio was confirmed by the single radial haemolysis test and an immunoassay specific for mumps virus. Antibodies against the mumps virus envelope glycoprotein, M-protein, and nucleoprotein could be demonstrated by immunoprecipitation and the antibody patterns in serum and CSF were similar. Antibodies against other microorganisms were not detected in the patient's CSF, and mumps antibodies were not found in the CSF specimens of 57 control patients. This case may be an example of a new disease—chronic mumps virus infection in the central nervous system.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Finlande</li>
</country>
<region>
<li>Uusimaa</li>
</region>
<settlement>
<li>Helsinki</li>
</settlement>
<orgName>
<li>Université d'Helsinki</li>
</orgName>
</list>
<tree>
<country name="Finlande">
<region name="Uusimaa">
<name sortKey="Vaheri, Antti" sort="Vaheri, Antti" uniqKey="Vaheri A" first="Antti" last="Vaheri">Antti Vaheri</name>
</region>
<name sortKey="Julkunen, Ilkka" sort="Julkunen, Ilkka" uniqKey="Julkunen I" first="Ilkka" last="Julkunen">Ilkka Julkunen</name>
<name sortKey="Koskiniemi, Marja Leena" sort="Koskiniemi, Marja Leena" uniqKey="Koskiniemi M" first="Marja-Leena" last="Koskiniemi">Marja-Leena Koskiniemi</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001686 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001686 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:79E24744BB9DB8750D760A50C64896A62FF66760
   |texte=   CHRONIC ENCEPHALOMYELITIS WITH SPECIFIC INCREASE IN INTRATHECAL MUMPS ANTIBODIES
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021